Elysium Health is a life sciences company developing clinically validated health products based on advancements in scientific research.
Elysium Health is focused on exploring compelling scientific advancements that have the potential to benefit everyone.
Elysium Health was founded in 2014 by Leonard Guarente, Dan Alminana, and Eric Marcotulli. The company is headquartered in New York, New York.
Elysium Health's™ mission is to solve the biggest challenges in health with science, to help people lead healthier lives.
Elysium works directly with top scientists, clinicians and health professionals around the world to translate advances in science and technology into innovative health products that work.
Elysium Health’s first product, Basis, is a proprietary formulation of two ingredients designed to support long-term health at the cellular level. Basis is clinically proven to increase NAD+ levels, which decline with age.
Elysium Health is backed by Silicon Valley Bank, General Catalyst, Morningside Ventures, GISEV Family Office, Mayo Clinic Ventures, Western Technology Investment (WTI) and others. The company raised The company raised $40M in a Series C equity and debt financing on Dec 23, 2019. This new round brings Elysium's total funding to $71.2M to date.